Literature DB >> 17159742

Frequency rhythmic electrical modulation system (FREMS) on H-reflex amplitudes in healthy subjects.

M Barrella1, R Toscano, M Goldoni, M Bevilacqua.   

Abstract

AIM: Changes in the amplitude of Hoffmann reflex (H-reflex) may reflect variations in the characteristics of the largely monosynaptic circuitry that is explored and are a possible target for diagnostic and physical therapeutic intervention. However, previous attempts to induce predictable changes in the H-reflex amplitude by transcutaneous electrical nervous stimulation (TENS) have generally failed. Previous workers applied fixed frequency in the low- (2-5 Hz) or in the high- (100 Hz) field, but they did not attempt to vary frequency and/or impulse duration in time.
METHODS: We evaluated the effect of a new type of painless electric stimulation, i.e. frequency rhythmic electrical modulation system (FREMS). FREMS is characterized by the use of transcutaneous electric pulses with sequentially modulated frequency (f: 1-39 Hz) and width (w: 10-40 micro s) at constant, perceptive threshold voltage (approximately 150 V). FREMS was applied at the abductor hallucis muscle (AHM), as conditioning stimulus of the H-reflex which was recorded ipsilaterally at the soleus muscle, according to the classic method, in 10 normal volunteers (age range 21-40 years).
RESULTS: H-reflex amplitude was substantially decreased (-50%) during FREMS and H-reflex amplitude variations were influenced by w/f variation in time during FREMS subphase C in a predictable way (r(2)=0.43; P<0.001). Our results suggest an effective ability of FREMS to modulate H reflex amplitude.
CONCLUSIONS: The ability to achieve large and predictable changes of the H-reflex amplitude simply by modulating both frequency and duration of a conditioning painless electrical stimulation offers new possibilities for the treatment of diseases characterized by motoneuron excitability abnormalities.

Entities:  

Mesh:

Year:  2006        PMID: 17159742

Source DB:  PubMed          Journal:  Eura Medicophys        ISSN: 0014-2573


  4 in total

1.  Induction of vascular endothelial growth factor release by transcutaneous frequency modulated neural stimulation in diabetic polyneuropathy.

Authors:  M Bevilacqua; L J Dominguez; M Barrella; M Barbagallo
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

2.  Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial.

Authors:  E Bosi; G Bax; L Scionti; V Spallone; S Tesfaye; P Valensi; D Ziegler
Journal:  Diabetologia       Date:  2012-12-13       Impact factor: 10.122

3.  Successful Treatment of Dercum's Disease by Transcutaneous Electrical Stimulation: A Case Report.

Authors:  Sabina Martinenghi; Amelia Caretto; Claudio Losio; Marina Scavini; Emanuele Bosi
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

4.  Transcutaneous electrical stimulation therapy and genetic analysis in Dercum's disease: A pilot study.

Authors:  Amelia Caretto; Edoardo Errichiello; Maria Grazia Patricelli; Orsetta Zuffardi; Giulia Cristel; Silvia Ravelli; Marcella Sirtori; Marina Scavini; Emanuele Bosi; Sabina Martinenghi
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.